Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) SHH

Currency In CNY

AD

Valuation

Market Cap5.52B
Enterprise Value4.05B
P/E Ratio138.68
PEG Ratio-1.92
Price/Sales Ratio11.91
Price/Book Ratio2.22
Enterprise/Revenue8.83
Enterprise/EBITDA78.54

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.06
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue448.37M
Revenue/Share3.07
Gross Profit448.37M
EBITDA35.47M
Net Income46.8M
Diluted EPS0.32

Balance Sheet

Total Cash1.4B
Total Cash/Share9.59
Total Debt435,359
Total Debt/Equity0
Current Ratio14.11
Book Value Per Share16.16

Price History

52-Week Change6.91
52-Week High50.98
52-Week Low30.4
Moving Average 50 Days37.84
Moving Average 200 Days38.92

Statistics

Average Volume2.92M
Shares Outstanding149.33M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.7
Trailing Annual Dividend Yield1.95
Payout Ratio3.91
Last Split FactorN/A
Last Split DateN/A
AD